Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D.

被引:0
|
作者
M. B. Graeber
S. Kösel
E. Grasbon-Frodl
H. J. Möller
P. Mehraein
机构
[1] Molecular Neuropathology Laboratory,
[2] Department of Neuromorphology,undefined
[3] Max Planck Institute of Neurobiology (formerly Max-Planck-Institute of Psychiatry,undefined
[4] Basic Sciences Institute),undefined
[5] Am Klopferspitz 18a,undefined
[6] D-82152 Martinsried,undefined
[7] Germany e-mail: neuropat@neuro.mpg.de,undefined
[8] Tel.: +49-89-85783666,undefined
[9] Fax: +49-89-89950077,undefined
[10] Molecular Neuropathology Laboratory,undefined
[11] Institute of Neuropathology,undefined
[12] Ludwig Maximilians University,undefined
[13] Munich,undefined
[14] Germany,undefined
[15] Psychiatric Clinic,undefined
[16] Ludwig Maximilians University,undefined
[17] Munich,undefined
[18] Germany,undefined
来源
Neurogenetics | 1998年 / 1卷
关键词
Key words Alzheimer disease; Amyloid plaques; APOE gene; Dementia; Neurofibrillary tangles;
D O I
暂无
中图分类号
学科分类号
摘要
Alois Alzheimer published two papers on the disease which was named after him by Emil Kraepelin in 1910. Each of these papers contains clinical and pathological data on a patient Alzheimer had seen at the hospital. We have previously reported on the rediscovery of tissue sections from Alzheimer's second published case of Alzheimer disease, Johann F., which probably gave the disease its name (Neurogenetics 1997; 1 : 73–80). Here, we describe the histopathology and APOE genotype of Alois Alzheimer's first patient, Auguste D. As in the case of Johann F., a large number of tissue sections belonging to Alzheimer's laboratory, which was later headed by Spielmeyer, were found among material kept at the Institute of Neuropathology of the University of Munich. As described by Alzheimer in his original report (Allg Zeitschr Psychiatr 1907; 64 : 146–148), there were numerous neurofibrillary tangles and many amyloid plaques, especially in the upper cortical layers of this patient. Yet, there was no microscopic evidence for vascular, i.e., arteriosclerotic, lesions. Interestingly, Alzheimer's histological preparations did not include the hippocampus or entorhinal region. The APOE genotype of this patient was shown to be ε3/ε3 by PCR-based restriction enzyme analysis, indicating that mutational screening of the tissue is feasible. The historical importance of the case of Auguste D. lies in the fact that it marks the beginning of research into Alzheimer disease. In addition, neurofibrillary tangles were first described in this brain.
引用
收藏
页码:223 / 228
页数:5
相关论文
共 50 条
  • [41] Influence of Western diet and APOE genotype on Alzheimer's disease risk
    Sullivan, P. M.
    [J]. NEUROBIOLOGY OF DISEASE, 2020, 138
  • [42] The distribution of cerebrovascular amyloid in Alzheimer’s disease varies with ApoE genotype
    Dimitri Trembath
    John F. Ervin
    Lucy Broom
    Mari Szymanski
    Kathleen Welsh-Bohmer
    Carl Pieper
    Christine M. Hulette
    [J]. Acta Neuropathologica, 2007, 113 : 23 - 31
  • [43] Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease
    Wang, JC
    Kwon, JM
    Shah, P
    Morris, JC
    Goate, A
    [J]. NEUROLOGY, 2000, 55 (11) : 1644 - 1649
  • [44] Imaging studies and APOE genotype in persons at risk for Alzheimer's disease
    Scarmeas N.
    Stern Y.
    [J]. Current Psychiatry Reports, 2006, 8 (1) : 11 - 17
  • [45] Relationship between Inflammatory Mediators, Aβ Levels and ApoE Genotype in Alzheimer Disease
    Reale, M.
    Kamal, M. A.
    Velluto, L.
    Gambi, D.
    Di Nicola, M.
    Greig, N. H.
    [J]. CURRENT ALZHEIMER RESEARCH, 2012, 9 (04) : 447 - 457
  • [46] APOE Genotype and Alzheimer's Disease: The Influence of Lifestyle and Environmental Factors
    Angelopoulou, Efthalia
    Paudel, Yam Nath
    Papageorgiou, Sokratis G.
    Piperi, Christina
    [J]. ACS CHEMICAL NEUROSCIENCE, 2021, 12 (15): : 2749 - 2764
  • [47] The Synergistic Effects of APOE Genotype and Obesity on Alzheimer's Disease Risk
    Jones, Nahdia S.
    Rebeck, G. William
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (01):
  • [48] Association between APOE genotype and psychiatric symptoms in Alzheimer's disease
    Scarmeas, N
    Tycko, B
    Devanand, D
    Riba, A
    Megargee, E
    Marder, K
    Bell, K
    Albert, M
    Brandt, J
    Stern, Y
    [J]. ANNALS OF NEUROLOGY, 2001, 50 (03) : S43 - S43
  • [49] Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease
    Salloway, S
    Gur, T
    Berzin, T
    Zipser, B
    Correia, S
    Hovanesian, V
    Fallon, J
    Kuo-Leblanc, V
    Glass, D
    Hulette, C
    Rosenberg, C
    Vitek, M
    Stopa, E
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 203 : 183 - 187
  • [50] APOE genotype and response to galantamine treatment in Alzheimer's disease.
    Aerssens, J
    Raeymaekers, P
    Lilienfeld, S
    Parys, W
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A195 - A195